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1. Introduction
The use of immobilized antibodies is popular in analyti-
cal techniques such as enzyme-linked immunosorbent assays 
(ELISAs), immunosensors, chromatographic immunoassays, 
and immunoaffinity chromatography [1–9]. The ability of an 
antibody to recognize a specific target and bind this with high 
affinity gives these methods good selectivity and low limits of 
detection [7–14]. In addition, the use of immobilized antibody 
supports in combination with other methods (e.g., reversed-
phase chromatography) has seen growing use in environmen-
tal and biological applications as a means for extracting and 
concentrating a given group of analytes from complex sam-
ples [8, 9, 15–22].
The design and optimization of these techniques requires 
information on how the immobilized antibodies will bind and 
dissociate from their target compounds. Surface plasmon res-
onance (SPR) is one approach for obtaining equilibrium and 
rate constants for the binding of antibodies to these targets 
[23–31]; however, this method does have limitations. One lim-
itation is that this method is restricted to materials that have 
appropriate optical properties for SPR measurements. In addi-
tion, SPR tends to work best for studying the binding of large 
analytes to an immobilized ligand because it is easiest to mon-
itor the changes in signal under such conditions. An alterna-
tive approach that could be used to examine the binding of an-
tibodies to a small target would be to immobilize the target 
and use soluble antibodies. However, this gives a system that 
may have different mass transfer properties and immobiliza-
tion effects than a system that uses an immobilized antibody 
support [26–28], which could lead to errors when applying the 
results of thermodynamic or kinetic measurements from one 
system to the other.
This current report explores an alternative approach for ex-
amining the binding of analytes to immobilized antibodies by 
using high-performance affinity chromatography (HPAC). 
Like SPR, it is known that affinity chromatography can be used 
to obtain both kinetic and thermodynamic information on a sol-
ute–ligand interaction, but this is now accomplished by look-
ing at the changes in elution profile of an analyte as it passes 
through a support containing the immobilized ligand [32–37]. 
Because this approach uses a post-column device to detect the 
analyte, there are no limitations on the type of support that can 
be examined; it is possible to utilize this method with the same 
type of material and immobilized ligand that will be used in 
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A system based on high-performance affinity chromatography was developed for characterizing the binding, 
elution and regeneration kinetics of immobilized antibodies and immunoaffinity supports. This information 
was provided by using a combination of frontal analysis, split-peak analysis and peak decay analysis to deter-
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ditions. This technique was tested using immunoaffinity supports that contained monoclonal antibodies for 
2,4-dichlorophenoxyacetic acid (2,4-D). Association equilibrium constants measured by frontal analysis for 
2,4-D and related compounds with the immobilized antibodies were 1.7–12 × 106 M−1 at pH 7.0 and 25 °C. Split-
peak analysis gave association rate constants of 1.4–12 × 105 M−1 s−1 and calculated dissociation rate constants of 
0.01–0.4 s−1 under the application conditions. Elution at pH 2.5 for the analytes from the antibodies was exam-
ined by peak decay analysis and gave dissociation rate constants of 0.056–0.17 s−1. A comparison of frontal anal-
ysis results after various periods of column regeneration allowed the rate of antibody regeneration to be exam-
ined, with the results giving a first-order regeneration rate constant of 2.4 × 10−4 s−1. This combined approach 
and the information it provides should be useful in the design and optimization of immunoaffinity chromatog-
raphy and other analytical methods that employ immobilized antibodies. The methods described are not lim-
ited to the particular analytes and antibodies employed in this study but should be useful in characterizing 
other targets, ligands and supports.
Keywords: biointeraction analysis, immunoaffinity chromatography, high-performance affinity chromatogra-
phy, split-peak analysis, peak decay analysis, frontal affinity chromatography, antibody–antigen interactions, 
kinetic studies
165
166 Ne ls o N, Mo s e r, & Hag e i N Jou r na l of Chr o ma t og r a p hy B 878  (2010) 
the analytical method being optimized or developed. In addi-
tion, it is possible in this chromatographic approach to use a 
wide range of detectors (e.g., UV–vis, fluorescence, and mass 
spectrometry). This allows the detection of smaller analytes 
than in SPR and makes it easier to study the interactions of 
small molecules with immobilized ligands [35, 37].
This work will consider the development and use of an in-
tegrated approach based on affinity chromatography for ex-
amining immobilized antibody supports. The approach will 
be tested and illustrated by using antibodies against 2,4-di-
chlorophenoxyacetic acid (2,4-D) and related herbicides as a 
model. Items to be evaluated will include the association equi-
librium constants and binding capacity of the immobilized an-
tibodies, as well as their association and dissociation rate con-
stants under sample application conditions. The dissociation 
rates of retained analytes under the column elution conditions 
will also be examined along with the rate of regeneration for 
the immobilized antibodies after sample elution. The theory 
behind these measurements will be discussed, and a few ex-
amples will be given that show how this information can be 
used to predict the performance of an immobilized antibody 
support when it is later employed for immunoaffinity chroma-
tography and compound analysis.
2. Methods
2.1. Reagents
The E2/G2 monoclonal anti-2,4-D antibodies were provided 
by the Vet Research Center (Brno, Czech Republic) [38]. Nu-
cleosil Si-1000 (7 μm particle diameter, 1000 Å pore size) was 
obtained from P.J. Cobert (St. Louis, MO, USA). The 2,4-D; 
2,4-dichlorophenoxyacetate methyl ester (2,4-D-Me); 2,4,5-tri-
chlorophenoxyacetic acid (2,4,5-T); 4-chloro-2-methylphenoxy-
acetic acid (MCPA); and 4-chlorophenoxyacetic acid (4-CPA) 
were from Sigma–Aldrich (St. Louis, MO, USA). Reagents for 
the micro bicinchoninic acid (BCA) protein assay were from 
Pierce (Rockford, IL, USA). All solutions were prepared with 
water from a Nanopure system (Barnstead, Dubuque, IA, USA). 
All other reagents were of the highest grades available.
2.2. Apparatus
The chromatographic system consisted of ten-port and six-
port Rheodyne LabPro electronically actuated valves from 
Alltech (Deerfield, IL, USA) along with three MicroStar pumps 
and one K-2500 UV–vis detector from Sonntek (Upper Sad-
dle River, NJ, USA). Data acquisition was performed using 
an SCB-68 NI shielded interface and 16E series PCMCIA card 
from National Instruments (Austin, TX, USA). Data were col-
lected using a Gateway Solo 2500 laptop computer (Poway, 
CA, USA) and analyzed with a spreadsheet prepared using 
Microsoft Excel (Microsoft, Redmond, WA, USA) (see Refer-
ence 39 for details on the spreadsheet).
The diol-bonded silica used in antibody immobilization was 
prepared from Nucleosil Si-1000 according to previous meth-
ods [40]. The coverage of diol groups on this support was found 
by an iodometric capillary electrophoresis assay [41] to be 38 
(±7) μmol diol/g silica (±1 SD). The E2/G2 monoclonal anti-2,4-
D antibodies were immobilized onto this support by the Schiff 
base method [42], with the immobilization being carried out at 
4 °C for three days. The antibodies were added to the silica in a 
slurry at a ratio of 1 mg protein/50 mg silica in a total volume of 
approximately 5 mL. After this immobilization had been com-
pleted, the resulting antibody silica was washed several times 
with pH 7.0, 0.1 M potassium phosphate buffer and stored in 
this buffer at 4 °C until use. A small portion of the antibody sil-
ica was dried under vacuum at room temperature and assayed 
for its protein content by a micro BCA protein assay, with re-
agent grade rabbit IgG (Sigma–Aldrich) being used as the stan-
dard. The protein coverage, as determined in triplicate by this 
method, was 15.9 (±0.2) mg antibody/g silica.
The antibody silica was packed into a 1 cm × 2.1 mm i.d. 
column according to a previous method [43] using a pres-
sure of 3000 psi applied for 30 min and pH 7.0, 0.1 M potas-
sium phosphate buffer as the packing solution. A column of 
equal length and diameter was packed by the same technique 
with Nucleosil that had been processed in a similar manner to 
the antibody silica but without the addition of any antibodies. 
This control column was used to correct for non-specific bind-
ing of analytes to the support.
2.3. Chromatographic studies
The samples contained 0–100 ng/L of the desired analyte 
in the application buffer (pH 7.0, 0.1 M potassium phosphate 
buffer). The elution buffer later passed through the antibody 
column was typically pH 2.5, 0.1 M potassium phosphate buf-
fer, but buffers with pH values of 2.5–5 were also examined. 
The elution of 2,4-D and all other analytes was monitored at 
223 nm. All the chromatographic studies were performed at 
room temperature (22–25 °C). All time values used in the ki-
netic measurements were corrected for the void time of the 
system, which was approximately 0.3 min at 0.4 mL/min.
Each study began by continuously applying a sample of 
the analyte onto both the control column and antibody column 
under identical flow rate and temperature conditions. These 
columns were originally equilibrated for 15 min in the appli-
cation buffer before coming into contact with the analyte. Sub-
sequent equilibration times were varied to measure the effects 
of regeneration time on the antibody column. After this equil-
ibration period, the sample was continuously applied to the 
column until a breakthrough curve with a well-defined pla-
teau was obtained. This typically required 5 min at a flow rate 
of 0.4 mL/min for applied solutions of 2,4-D or the other ana-
lytes; however, at lower flow rates or more dilute analyte con-
centrations longer times were allowed for this step as needed. 
The application flow rate was varied from 0.2 mL/min to 
0.75 mL/min during these studies, with each set of studies 
being performed in duplicate or triplicate. The overall break-
through curves that were produced through this process were 
then analyzed to determine the binding capacities and associa-
tion constants for the interaction of the analyte with the immo-
bilized antibodies (see Section 3.2). The overall shape of these 
same curves, particularly in the early stages of analyte applica-
tion, was used to also provide information on the rate of ana-
lyte adsorption to the immobilized antibodies (see Section 3.3).
Analyte release from the antibody column was accom-
plished by passing an appropriate elution buffer through the 
system. This caused the retained analytes to dissociate from the 
immobilized antibodies and leave the column. A background 
peak resulted during this step due to the change in buffer com-
position. To correct for this peak, the response obtained under 
the same conditions for the control column was subtracted from 
that for the antibody column. The background corrected results 
were then used to examine the dissociation kinetics of each an-
alyte from the immobilized antibody column in the presence 
of the given elution buffer (see Section 3.4). The elution buf-
fer was typically passed through these columns for 3 min at 
0.5 mL/min; however, other studies were performed in which 
the elution buffer had a flow rate of 0.2–0.5 mL/min and passed 
through the column for 2–5 min. The results under each set of 
conditions were measured at each of the concentrations used in 
the frontal analysis work, as described previously, and through 
the use of at least duplicate or triplicate studies.
Column regeneration was performed by reapplying the 
original application buffer to the column after the elution step. 
Frontal analysis was then used to see how the measured bind-
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ing capacity of the antibody column changed for 2,4-D as a 
function of the regeneration time. This work was performed 
using various regeneration times (1.0–5.0 min) and flow rates 
(0.5–1.5 mL/min) for washing the antibody column with pH 
7.0, 0.1 M potassium phosphate buffer before beginning the 
application of analyte. After data from all of these steps had 
been acquired, this information was placed into a Microsoft 
Excel spreadsheet for data analysis and the determination of 
binding capacities, equilibrium constants, and rate constants, 
as discussed later in Section 3.
3. Results and discussion
3.1. General analysis scheme
The reaction scheme used in this study to characterize the 
immobilized antibodies is shown in Figure 1. This model is 
based on the on/off elution scheme that is commonly used 
in affinity chromatography for the separation and analysis 
of targets with strong binding to an immobilized antibody 
or affinity ligand [7, 14]. A typical example of such a scheme 
for the immobilized antibodies that were investigated in this 
study is shown in Figure 2. The first step in this scheme is to 
apply the analyte (A) to the ligand (L) and wash away non-
retained components with an application buffer. The second 
step involves dissociation and elution of the retained analyte 
in the presence of an elution buffer. Due to the large associa-
tion constants that are present for most antibodies at a phys-
iological pH, this dissociation step generally requires the use 
of a pH step change or the addition of a modifier to alter in-
teractions between the analyte and antibody [7, 14, 29]. The 
ligand is allowed to regenerate during the third step. It is 
during this step that an application buffer/regeneration solu-
tion is reapplied to the column, allowing the immobilized li-
gand to return to its initial conformation before the next sam-
ple application [7, 14].
In SPR, the association and dissociation events for analyte–
ligand systems are typically examined only during the appli-
cation step in Figures 1 and 2 (i.e., under reaction conditions 
at or near physiological conditions). The elution and regener-
ation steps are generally ignored in SPR during quantitative 
measurements and are only performed as part of the clean-up 
process for the sensor [29, 31] (note: dissociation kinetics can 
be examined by SPR when washing the surface with a buffer 
containing no analyte [31, 36] and have in some cases been ex-
amined in the presence of a different elution buffer [44]). In 
this current study, kinetic information generated by HPAC 
during both elution and regeneration was also considered as a 
means to provide a more complete description of the behavior 
of a given analyte and immobilized ligand. The overall pro-
cess that was used in this report will be demonstrated in the 
following sections, in which the information obtained during 
sample application, elution and column regeneration will each 
be examined in turn during the characterization of an immu-
noaffinity support.
3.2. Degree of analyte retention during application
The interactions that occurred during the first step in Fig-
ures 1 and 2 (sample application) were examined by using 
frontal analysis (i.e., frontal affinity chromatography). In this 
method, a known concentration of the analyte [A] is applied 
to the column at a fixed flow rate while the amount of ana-
lyte exiting from the column is monitored. As the column be-
comes saturated, this process results in a breakthrough curve 
in which the mean position of this curve is related to the bind-
ing capacity of the column. For monoclonal antibodies or li-
gands with single-site binding, this data can be examined us-
ing the following equation [35],
                 1       =            1        +   1             (1)
           (mL,app)       (mLKA[A])      mL
where KA is the association equilibrium constant for the bind-
ing of A to the immobilized ligand, mL,app is the apparent 
moles of analyte required to reach the mean position of the re-
sulting breakthrough curve at a given concentration of applied 
analyte [A], and mL is the total mole of binding sites in the col-
umn for A. Equation (1) indicates that a plot of 1/(mL,app) ver-
sus 1/[A] for a homogeneous system with 1:1 binding should 
give a straight line with a slope equal to 1/(mLKA) and an in-
tercept equal to 1/(mL). The binding capacity can then be ob-
tained by taking the reciprocal of the intercept, and an esti-
mate of the association equilibrium constant can be obtained 
by dividing the intercept by the slope.
Equation (1) works well for ligands with weak-to-moderate 
affinities but can also be used for high affinity ligands if mea-
surable dissociation is present, thus allowing the creation of a 
local equilibrium at the mean point of the breakthrough curve. 
For antibodies, typical association constants are often in the 
range of 105–1012 M−1. Equation (1) is particularly useful for 
monoclonal antibodies, which tend to have association equi-
librium constants at the lower end of this range (KA < 109 M−1); 
however, even with higher affinity ligands the intercept of 
Equation (1) can be used to provide an estimate of the total 
binding capacity for an affinity column.
Figure 1. General kinetic processes used in this study to model the 
binding and elution of an analyte in affinity chromatography. In this 
model, kA and kD are the association and dissociation rate constants 
for analyte–antibody interactions during sample application, kD* is the 
first-order dissociation rate constant describing analyte elution, and kR 
is the first-order rate constant that describes the regeneration of the 
immobilized antibodies.
Figure 2. A typical chromatogram obtained in this study for the ex-
amination of analyte binding and elution from an immunoaffinity col-
umn. The lighter line shows a chromatographic performed on a con-
trol column containing no antibodies, while the heavier line gives the 
results obtained for analytes on an immobilized antibody support.
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Figure 3 shows some typical plots that were obtained in 
this study when the mean positions of frontal analysis curves 
for anti-2,4-antibody supports were analyzed according to 
Equation (1) [35]. As shown in this figure, plots of 1/mL,app 
versus 1/[A] were found to give reasonably good agreement 
with a linear fit for the various analytes that were tested under 
the application conditions used in this study. The slopes and 
intercepts of these plots were then used with Equation (1) to 
obtain the total binding capacity (mL) and association equilib-
rium constant (KA) of the immobilized antibodies for each of 
the applied analytes.
The original binding capacity obtained for 2,4-D on this 
antibody column was 7.7 (±1.4) × 10−10 mol. Statistically 
equivalent or similar values ranging from 7 × 10−10 mol to 
12 × 10−10 mol were obtained for the related analytes that were 
tested (i.e., 2,4-D-Me; 2,4,5-T; 4-CPA; and MCPA). Based on 
the measured protein content of the support in this column 
(15.9 mg antibody/g silica) and the known packing density of 
the support (0.45 g/cm3), the total antibody content of this col-
umn was estimated to be 3.4 × 10−9 mol. This meant that 34–
49% of these antibodies retained their activity for binding to 
2,4-D and related compounds after immobilization, as based 
on a 1:1 binding model.
The linear behavior noted for the plots in Figure 3 indicated 
that Equation (1) could be used to obtain the association equi-
librium constants for the anti-2,4-D column with each of the 
tested analytes. Using this approach, it was found for the five 
related but distinct compounds examined in this study that 
the resulting association equilibrium constants ranged from 
1.7 × 106 M−1 to 12 × 106 M−1 under the application conditions, 
as summarized in Table 1. The differences in these values indi-
cate that slightly different interactions are occurring between 













column; however, this overall range of values is typical of 
what would be expected for monoclonal antibodies and are 
well within the range of equilibrium constants that are ame-
nable to measurement by frontal analysis. The result of 12.0 
(±1.0) × 106 M−1 obtained for 2,4-D is comparable, although not 
statistically identical, to previous measurements performed 
with the same antibodies using a quartz crystal microbalance, 
in which 2,4-D was found to have an association constant of 
5.75 × 106 M−1 in the presence of pH 7.0, 0.05 M phosphate buf-
fer [38]. The approximately two-fold difference in these latter 
values may have been due to differences in the particular so-
lution and measurement conditions or in the immobilization 
methods that were used in these two studies [7].
It was possible from the measured binding capacities and 
association equilibrium constants to estimate the retention fac-
tor (k) for each analyte on the immunoaffinity support under 
the application conditions. This value was calculated by us-
ing the relationship k = (KAmL)/VM, where VM is the void vol-
ume of the column. Using an average initial binding capacity 
of 8 × 10−10 mol gave a retention factor at pH 7.0 and 25 °C that 
was greater than 330 for 2,4-D and MCPA and retention factors 
that were between roughly 50 and 100 for the other analytes. 
The results for 2,4-D and MCPA represented reasonably strong 
retention. For instance, at 0.5 mL/min a small plug of 2,4-D or 
MCPA would require at least 18–20 min to pass through the im-
munoaffinity column under the application conditions. This re-
sult indicated that the given anti-2,4-D antibody columns could 
be successfully used to extract and retain 2,4-D and MCPA from 
samples. The other tested analytes would have retention times 
ranging from 2.8 min (4-CPA) to 5.5 min (2,4,5-T) under the 
same conditions. Careful control of the application and wash 
step could also allow the anti-2,4-D antibody column to be used 
for the immunoextraction of these agents, as has been demon-
strated in recent simulations of immunoaffinity/reversed-phase 
systems [22] and in past work examining the binding of anti-at-
razine immunoaffinity columns for triazine herbicides and their 
degradation products [10, 21].
3.3. Kinetics of analyte retention
The association and dissociation kinetics of each analyte 
during the application step were also examined in this study. 
If the support is an efficient material with relatively fast mass 
transfer from the bulk solution to the surface or interior of the 
support, the rate of capture of the analyte during application 
process can be modeled by using an adsorption-limited pro-
cess [35, 37]. The situation occurs when the rate of binding is 
limited by the association of the molecule to the antibody. This 
type of reaction has been successfully used in the past to de-
scribe the adsorption of analytes to HPLC-based immunoaffin-
ity supports (e.g., see Reference [32]). This process is described 
in Figure 1 by a second-order adsorption rate constant (kA) 
and a first-order dissociation rate constant (kD).
One way in which the rate of this binding can be measured 
is by measuring the fraction f of the analyte that is non-re-
tained or “free” at various flow rates [32–34, 37, 45–46]. Under 
adsorption-limited conditions and in the case where the rate of 
analyte dissociation is slow and negligible versus analyte ad-
sorption, this free and non-retained fraction can be related to 
the flow rate (F), association rate constant, number of active 
binding sites in the column, and amount of applied analyte, as 
shown in Equation (2) [32].
               f = {      So     }  ln [1 + eLoadA/So – 1) e–1/So ]     (2)                       Load A
In this equation, the term So is equal to F/(kAmL) and Load A 
is the ratio of the moles of applied analyte compared to the 
moles of binding sites in the column, where Load A = (mol 
Figure 3. Analysis of the association equilibrium constants for several 
compounds as they were bound by immunoaffinity columns contain-
ing immobilized anti-2,4-D antibodies. These data were analyzed ac-
cording to Equation (1) for 2,4-D (◊), 2,4-D-Me (□), 2,4,5-T (∆), 4-CPA 
(○), and MCPA (*), giving correlation coefficients of 0.96, 0.86, 0.98, 
0.99 and 0.93, respectively. Each of the data points shown in this plot 
is the average for duplicate or triplicate measurements. Part of the dif-
ference in the intercepts of these particular plots (e.g., the 2,4-D results 
versus 2,4-D-Me) is a result of loss of some activity over time for the 
immunoaffinity columns.
Table 1. Association equilibrium constants and association/dissociation 
rate constants of anti-2,4-D monoclonal antibodies at pH 7.0 and 25 °Ca.
Analyte            KA (×106 M−1)         kA (×105 M−1 s−1)      kD (s−1)
2,4-D 12.0 (±1.0) 3.4 (±0.7) 0.028 (±0.006)
MCPA 11.8 (±2.7) 1.4 (±0.5) 0.012 (±0.005)
2,4,5-T 3.4 (±0.5) 12.0 (±2.0) 0.36 (±0.08)
2,4-D-Me 2.4 (±0.8) 4.1 (±0.8) 0.17 (±0.07)
4-CPA 1.7 (±0.3) 2.6 (±0.7) 0.15 (±0.05)
a The values for KA, kA, and kD were calculated as described in text. 
The numbers shown in parentheses represent a range of ±1 SD.
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A)/mL. Using Equation (2), non-linear application conditions 
can be used to calculate the value of kA for an immobilized an-
tibody if the flow rate, amount of applied sample and bind-
ing capacity of the column are known. Equation (2) can also 
be used to estimate the binding capacity of the column, but in 
this study the binding capacity was instead obtained by using 
Equation (1), as described in the previous section, to reduce 
the number of variables that are present during the measure-
ment of kA (note: alternative kinetic methods based on fitting a 
frontal analysis profile are also available, as discussed in Ref-
erences 37 and 47–49).
As shown in Figure 4, a good fit was found for all analytes 
between Equation (2) and the early part of a frontal analysis 
curve for the immunoaffinity column (i.e., conditions under 
which analyte dissociation was essentially negligible; similar 
behavior has been seen for the methods described in References 
37 and 47–49). The best fit in this response occurred between 
Load A values of 0–2. The average deviations over this range 
between the predicted and experimental free fraction curves, as 
generated according to Equation (2), varied from 1.9% to 16% 
for the various analytes that were examined in this report. The 
association rate constants determined from these curves (see Ta-
ble 1) varied from 1.4 × 105 M−1 s−1 to 12 × 105 M−1 s−1 for bind-
ing of the immobilized 2,4-D antibodies to the targets examined 
in this work. The dissociation rate constants under the applica-
tion conditions were then calculated by using both these mea-
sured association rate constants and the KA values determined 
in the previous section, as given by the relationship KA = kA/kD. 
These dissociation rate constants are also listed in Table 1 and 
ranged from 0.012 s−1 to 0.36 s−1.
A previous report using a piezoelectric quartz crystal mi-
crobalance (QCM) gave an association rate constant of 4.5 
(±0.3) × 103 M−1 s−1 in the binding of 2,4-D to the same antibod-
ies as used in this report but using immobilized 2,4-D and solu-
ble antibodies [38]. However, it was found in this current study 
that using immobilized antibodies and soluble 2,4-D gave an as-
sociation rate constant of 3.4 (±0.7) × 105 M−1 s−1. This can be ex-
plained based on the fact that the rate of antibody binding tends 
to be diffusion-limited. In the case of the piezoelectric QCM, dif-
fusion would have been much slower since a large biomolecule 
(i.e., an antibody) had to diffuse to the sensor surface before it 
could bind to the immobilized 2,4-D. However, in this current 
study a faster rate of binding would have been expected since a 
small target (2,4-D) was now diffusing to a surface which con-
tained the immobilized antibodies. This difference indicates the 
importance of using the same support material and immobi-
lized agent in such kinetic studies as will be used in the final de-
sired application of such substances.
3.4. Kinetics of analyte elution
The rate of release of a retained analyte during elution (i.e., 
Step 2 in Figure 1) was also considered in this work. The rate 
of release for an analyte from a high affinity ligand (e.g., an 
antibody) when using a step gradient can be described as a 
first-order process,
                               kD*
                  A – L*  A* + L*   (3)
                                        kA*
where L*, A*, and A–L* represent the ligand, analyte, and ana-
lyte–ligand complex in the presence of the elution buffer, and 
kD* and kA* are the dissociation and association rate constants 
for the A–L* under these conditions. If A* is removed quickly 
from the column during elution and not allowed to rebind to 
the immobilized ligand, the association of A* with L* can be ig-
nored in the above reaction. The remaining dissociation pro-
cess can then be described by the following first-order rate law 
and integrated rate expression [37, 50–52],
                   –d[A – L*] = 
d[A*] = kD* [A*]
    (4)                           dt              dt
                    ln[A*] = −kD* t + ln[A*]0   (5)
where t is the time allowed for elution and [A*]0 is the amount 
of A* initially present in the system. According to Equation (5), 
a plot of ln[A*] versus t should be linear during elution with a 
slope equal to −kD*, the dissociation rate constant. Lineariza-
tion of the signal versus time has been used to determine the 
rate constants of many systems [50–55], and is adequate for 
calculating the dissociation rate constant for a system based on 
a simple bimolecular interaction such as the release of analyte 
from the antibody used in this model system [37, 50–52].
The results obtained for 2,4-D and related herbicides are 
shown in Figure 5. This elution was found to give a good fit 
with a first-order decay process with effective dissociation rate 
constants of 0.06–0.176 s−1 being obtained for the given ana-
lytes in the presence of pH 2.5, 0.10 M phosphate buffer. Al-
though a good fit was noted between these elution profiles 
and the first-order model, there was a decrease of (20–50%) 
noted in these apparent dissociation rate constants when the 
flow rate was decreased below 0.4–0.5 ml/min. This is be-
lieved to be due to a greater chance of reentry of the analytes 
in the pores of the support at low flow rates. It was also pos-
sible with this method to examine how the dissociation rate 
constant changed with elution pH. This result is summarized 
Figure 4. Fit between the experimental results and those predicted by 
Equation (2) for the application of a 100 ppb solution of 2,4,5-T to an im-
mobilized anti-2,4-D antibody column. The values of both f and Load 
A are unitless, as indicated by the definitions of these terms in the text.
Figure 5. First-order kinetic plots prepared according to Equation (5) for 
the elution of several analytes from immobilized anti-2,4-antibodies in 
the presence of pH 2.5, 0.10 M phosphate buffer. The “response” used 
in the logarithmic term on the y-axis was determined by using the ab-
sorbance measurements obtained for the elution profile after subtract-
ing the elution profile for the same analyte from the blank column.
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in Figure 6, where much faster elution was noted for 2,4-D as 
well as all related compounds from the anti-2,4-D antibodies 
as a change was made from a neutral to acidic elution pH.
These dissociation rate constants were also used to calcu-
late the amount of time required to recover a given fraction of 
an applied analyte from the immunoaffinity column. For in-
stance, when the anti-2,4-D antibody column is saturated, the 
initial amount of 2,4-D on the column is approximately equal 
to the binding capacity, or 2.4 × 10−10 mol. If the dissociation 
rate constant of the antibody column for 2,4-D is 0.145 s−1 un-
der the given elution conditions (e.g., pH 2.5), 90% of the 2,4-D 
will be recovered within 15.8 s. A recovery of 95% or 99% will 
take 20.7 s or 31.8 s, respectively. These results indicate that 
elution of essentially all the 2,4-D will take place in less than 
1 min. The 2,4-D-Me would require elution over 28.8 s, 37.5 s 
or 57.6 s for 90%, 95% or 99% recovery; for 2,4,5-T the times 
required to obtain the same recoveries would be 24.5 s, 31.9 s 
and 49.0 s. This information is helpful in ensuring that a high 
degree of each analyte has been dissociated from the immuno-
affinity support. A high recovery during elution is desirable 
to increase the signal that is obtained for each analyte and to 
minimize carryover effects when the immunoaffinity support 
is to be used over many sample injections.
3.5. Kinetics of column regeneration
The rate of regeneration for antibodies is another important 
issue to consider if the same support is to be used for multi-
ple assays. In this study, the rate of regeneration was exam-
ined by plotting the measured binding capacity of the column 
after regeneration versus the time allowed for regeneration of 
the column. Regeneration of antibodies after dissociation of 
analyte has occurred in the presence of an elution buffer may 
require the reformation of intra-molecular bonds. This regen-
eration is typically accomplished by returning the immunoaf-
finity support to its initial application buffer. It is important to 
determine the amount of time and/or solvent that is needed to 
return the antibody to its original conformation during the re-
generation step because the rate of this process can affect both 
the speed with which an assay can be conducted by immuno-
affinity chromatography and the practical lifetime of an im-
munoaffinity support.
Regeneration of an immunoaffinity support was modeled 
in this work by using the following first-order reaction,
                                 kR
                            L*  L       (6)
                                 k–R
where L* is the immobilized ligand in the dissociation state 
and L is the immobilized ligand in the binding state (see Figure 
 
1). As a first-order kinetic process, the regeneration rate that 
would be expected for this reaction is described by Equation (7).
             –d[L*] = 
d[L] = kR[L*] + k–R[L]
             (7)                 dt          dt
Assuming that the rate of the back reaction is negligible, the 
last term in Equation (7) goes to zero and the rate law becomes
             –d[L*] = kR[L*]     or
   –d(mol L*) = kR (mol L*)              (8)                 dt                                    dt
which can be integrated to give the expressions in Equation 
(9).
     ln[L*] = −kR t + ln[L*]0  or  ln(mol L*) = −kR t + ln(mol L*)0   (9)
This result indicates that a plot of −ln[L*] or −ln(mol L*) versus 
regeneration time will provide a straight line with a slope of −
kR and an intercept of ln[L*]0 or ln(mol L*)0 if antibody regener-
ation follows a first-order process.
The results that were obtained when this model was used 
to examine the experimental data are shown in Figure 7. It was 
found that a reasonable linear fit to Equation (9) was obtained, 
giving a correlation coefficient of 0.995. From this fit, the rate 
constant for antibody regeneration was determined to be 2.4 
(±0.3) × 10−4 s−1. It was determined from this result that 95% of 
the binding sites in the column were regenerated in less than 
1 min when using a step change from a pH 2.5 elution buffer 
to a pH 7.0 application buffer. This information could be valu-
able in designing an immunoaffinity system that is to be used 
over a large number of sequential injection, elution and regen-
eration cycles. The intercept of Figure 7 made it possible to es-
timate the initial amount of active binding sites that must have 
been present prior to regeneration with the anti-2,4-D anti-
body column. This estimated value was 6.3 (±0.1) × 10−10 mol, 
which was comparable to the original binding capacity of 
7–12 × 10−10 mol that was measured for the same immunoaf-
finity support by frontal analysis (see Section 3.2).
4. Conclusions
It was found in this study that the direct use of affinity 
chromatography is an effective and inexpensive method for 
determining equilibrium and rate constants for the binding of 
small molecules to monoclonal antibodies. This allowed infor-
mation to be obtained on the application, elution and regener-
ation kinetics of immobilized antibodies. This technique was 
tested using HPLC supports containing monoclonal antibod-
ies for 2,4-D. Association equilibrium constants measured for 
2,4-D and related compounds were 1.7–12 × 106 M−1 at pH 7.0 
Figure 6. Change in the measured dissociation rate constant with pH 
for the elution of 2,4-D from an immunoaffinity column containing 
anti-2,4-D-antibodies. Each of the data points shown in this plot is the 
average for duplicate or triplicate measurements.
Figure 7. Determination of the rate of regeneration for the immobi-
lized anti-2,4-D antibodies in going from pH 2.5, 0.10 M phosphate 
buffer to pH 7.0, 0.1 M phosphate buffer at a flow rate of 0.5 mL/min. 
Each of the data points shown in this plot is the average for duplicate 
or triplicate measurements.
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and 25 °C, with association and dissociation rate constants of 
1.4–12 × 105 M−1 s−1 and 0.01–0.4 s−1. Release of analytes from 
these antibodies at pH 2.5 followed a first-order decay model, 
with dissociation rate constants of 0.056–0.17 s−1. Regeneration 
of the immobilized antibodies also followed a first-order pro-
cess, with a regeneration rate constant of 2.4 × 10−4 s−1.
It was shown how the information that was obtained in this 
study can be useful in the design and optimization of analy-
sis methods employing immobilized antibodies. For instance, 
the binding capacities and association equilibrium constants 
determined by frontal analysis can be used to determine the 
overall degree of retention for an analyte under the sample ap-
plication conditions. Association rate constants can be used to 
determine the rate of analyte extraction, and dissociation rate 
constants can be used to predict the rate of analyte release un-
der a given set of elution conditions. The extent of column re-
generation can also be optimized by this approach.
The methods described in this study are not limited to the 
given analytes and antibodies but should also be useful in ki-
netic studies with other types of targets, ligands and supports. 
This approach allows all aspects of the sample application, 
elution and regeneration cycle to be examined for an immu-
noaffinity support. It should also be possible to use this ap-
proach with a wider variety of support materials and surfaces 
than can be currently examined by SPR. In addition, this chro-
matographic approach to kinetic studies can be adapted for 
use with a variety of detectors (i.e., as has already been dem-
onstrated for immunoaffinity chromatography in general) [7, 
8, 14], making it easier to use than SPR with dilute analytes or 
those that do not produce a large change in signal as they bind 
to the surface of an SPR sensor. All of these features make this 
approach an attractive alternative to SPR for the direct charac-
terization of immunoaffinity materials and for kinetic studies 
of immobilized biological molecules.
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